VICP
Vicapsys Life Sciences, Inc.Company Information
- Company Name
- Vicapsys Life Sciences, Inc.
- CIK
- CIK0001468639
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- VICP: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VICP
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2010-09-03
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 30,000
Institutional Sentiment
- As of
- 2022-06-30
- Institutional shares owned
- 10
- Shares outstanding
- 31,188,461
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2025-01-10
- Price on filing date
- —
- 1-month reaction
- -57.14%
- 3-month reaction
- -74.71%
Balance Sheet
Values in millions ($)| Line item | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | - | - | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Offering Costs | - | - | - | - | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Trade Current | - | - | - | 1 | 1 | 1 | 1 | 1 | - | - | - | - | ||||||
| Accounts Payable Current | - | - | - | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | ||||||
| Accounts Payable Related Parties Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Salaries Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Short Term Borrowings | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Short Term Bank Loans And Notes Payable | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Short Term Non Bank Loans And Notes Payable | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 1 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
| Stockholders Equity | -3 | -2 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -17 | -17 | -17 | -16 | -16 | -15 | -15 | -15 | -15 | -14 | -14 | -14 | ||||||
| Liabilities And Stockholders Equity | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Finite Lived Intangible Assets Accumulated Amortization | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | ||||||
| Preferred Stock Shares Authorized | 7 | 7 | 7 | 7 | 20 | 20 | 20 | 7 | - | - | - | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 32 | 32 | 32 | 32 | 32 | 31 | 31 | 31 | 31 | 31 | 31 | 20 | ||||||
| Shares Outstanding | 32 | 32 | 32 | 32 | 32 | 31 | 31 | 31 | 31 | 31 | 31 | 20 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVicapsys Life Sciences, Inc. (VICP) — SEC Financial Statements & Analysis
Vicapsys Life Sciences, Inc. (VICP) is a pharmaceutical preparations company, incorporated in FL. Vicapsys Life Sciences, Inc. trades on OTC as: VICP. Vicapsys Life Sciences, Inc. (VICP)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2025-01-10. Based on that filing, Vicapsys Life Sciences, Inc. carries a market cap of $240.29M, a P/E ratio of -178.33x, a P/B ratio of -90.82x, an enterprise value of $240.72M, and an EV/EBITDA multiple of -216.95x. On profitability, it posts a Return on Equity (ROE) of 67.72% and a Return on Assets (ROA) of -904.18%. Per share, it reports EPS of $-0.04, diluted EPS of $-0.04, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 25.19% year-over-year and EPS growth of 25.47% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.03x, working capital of $-2.65M, a debt-to-equity ratio of -1.03x, a debt ratio of 30.54, an interest coverage ratio of -9.97x, free cash flow of $-125.74K (TTM), and net debt of $421.83K. Figures sourced from SEC EDGAR.
- Market Cap
- $240.29M
- P/E TTM
- -178.33x
- EPS TTM
- $-0.04
- P/B TTM
- -90.82x
- ROE TTM
- 67.72%
- ROA TTM
- -904.18%
- Debt To Equity
- -1.03x
- Free Cash Flow TTM
- $-125.74K
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Vicapsys Life Sciences, Inc. in?
Vicapsys Life Sciences, Inc. (VICP) operates in the Pharmaceutical Preparations industry.
What exchange does VICP trade on?
Vicapsys Life Sciences, Inc. (VICP) trades on the OTC.
Where is Vicapsys Life Sciences, Inc. incorporated?
Vicapsys Life Sciences, Inc. is incorporated in FL.
When was Vicapsys Life Sciences, Inc. (VICP)'s most recent SEC filing?
Vicapsys Life Sciences, Inc. (VICP)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2025-01-10.
What is VICP's market cap?
Vicapsys Life Sciences, Inc. (VICP) has a market capitalization of $240.29M as of 2024-09-30.
What is VICP's EPS (earnings per share)?
Vicapsys Life Sciences, Inc. (VICP)'s trailing twelve month EPS is $-0.04 as of 2024-09-30.
What is VICP's ROE (return on equity)?
Vicapsys Life Sciences, Inc. (VICP)'s trailing twelve month Return on Equity (ROE) is 67.72% as of 2024-09-30.
What is VICP's ROA (return on assets)?
Vicapsys Life Sciences, Inc. (VICP)'s trailing twelve month Return on Assets (ROA) is -904.18% as of 2024-09-30.
What is VICP's EV/EBITDA?
Vicapsys Life Sciences, Inc. (VICP)'s trailing twelve month EV/EBITDA is -216.95x as of 2024-09-30.